Insulin Costs to Cap at $35 in Senate Bill Gains New Momentum
A bipartisan Senate bill to cap insulin for Americans at $35 has new momentum, reviving efforts that previously stalled, as lawmakers aim to make life-saving medication more affordable.
A bipartisan group of senators is resurfacing the INSULIN Act of 2026, a bill to cap insulin costs for Americans at $35 per month, in an effort to revive a push that previously stalled and provide relief to those struggling with high medication expenses. The legislation aims to make life-saving treatment more affordable for millions of Americans. With new momentum, the bill's prospects for passage have increased, offering hope for patients who are currently burdened by expensive insulin bills. The INSULIN Act would aim to stabilize healthcare costs for those relying on insulin therapy.
